Back to Journals » Vascular Health and Risk Management » Volume 8
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
17,534 | Dovepress* | 12,388+ | 3,128 | 15,516 | |
PubMed Central* | 5,146 | 1,867 | 7,013 | ||
Totals | 17,534 | 4,995 | 22,529 | ||
*Since 11 June 2012 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
7 | 0 | 0 | 0 | 1 | 6 |
View citations on PubMed Central and Google Scholar